Aterian, Inc. — FY2021 Form 10-K
Reporting period: Fiscal year ended December 31, 2021; filed March 16, 2022. This is an annual report, not a standalone Q4 report, and the filing text does not provide a clear Q4-only financial summary.
Business context
Aterian operates a technology-enabled consumer products business, using its AIMEE data and automation platform to develop, market, and sell products and to support acquired brands. It owned 14 brands at year-end, with products across home, kitchen, heating and cooling, health and beauty, and other categories. Sales are highly concentrated in online marketplaces: Amazon accounted for approximately 93% of FY2021 revenue, up from 88% in FY2020.
Financial performance and liquidity
| Metric | FY2021 | FY2020 |
|---|---|---|
| Net revenue | $247.8 million | $185.7 million |
| Gross profit / gross margin | $121.9 million / 49.2% | $84.7 million / 45.6% |
| Operating loss | $34.1 million | $34.8 million |
| Net loss | $236.0 million | $63.1 million |
| Adjusted EBITDA (non-GAAP) | $(7.2) million | $2.5 million |
| Contribution margin (non-GAAP) | $25.0 million / 10.1% | $25.1 million / 13.5% |
| Cash from (used in) operating activities | $(42.0) million | $6.1 million |
| Cash used in investing activities | $(44.9) million | $(39.1) million |
| Cash from financing activities | $95.6 million | $32.3 million |
At December 31, 2021, cash was $30.3 million and restricted cash was $8.0 million. Inventory rose to $63.0 million from $31.6 million. Current assets were $124.9 million and current liabilities were $83.7 million. The MidCap revolving facility had $32.8 million outstanding at year-end, against a facility of up to $40.0 million subject to a borrowing base; the prior High Trail term debt had been repaid. MidCap covenants require minimum liquidity of $12.5 million during February–May and $15.0 million at other times, or an alternative availability threshold.
Changes, outlook, and material risks
- Revenue mix: Revenue grew 33.4%, but organic revenue declined 19.9% to $118.4 million. M&A businesses contributed $120.9 million, compared with $16.3 million in FY2020. Management attributed the organic decline to weaker demand following retail reopening, price increases, and inventory shortages caused by supply delays.
- Margins and costs: Gross margin improved, largely because acquired businesses had higher gross margins than the organic business. However, sales and distribution expense rose to $127.4 million from $68.0 million, and contribution margin fell to 10.1% from 13.5%, reflecting higher shipping and fulfillment costs, product mix, and other expenses.
- Unusual loss items: FY2021 net loss included $138.9 million of loss on extinguishment of debt, $20.1 million of loss on initial warrant issuance, and $26.5 million of warrant fair-value expense. These items substantially increased the GAAP loss; they are not equivalent to operating cash outflows in the period. The company also recorded a $30.5 million gain from changes in contingent earn-out fair values.
- Funding and going concern: Management and the auditor reported substantial doubt about Aterian’s ability to continue as a going concern, citing recurring losses, negative operating cash flow, dependence on outside capital, and potential covenant compliance challenges. Management planned to seek capital, monitor forecasts, and pursue its acquisition strategy; it gave no assurance that financing or covenant relief would be available.
- Operating outlook: No formal revenue or earnings guidance is provided. Management said supply-chain cost and reliability pressures were expected to continue in the near term; the risk discussion estimated adverse effects for at least six to nine months. Product launches had been paused, and management warned of possible working-capital tightness in the first half of 2022 and first quarter of 2023 as inventory was secured earlier and at higher levels.
- Acquisitions and financing: FY2021 acquisitions included Healing Solutions, Squatty Potty, and Photo Paper Direct. A March 2022 private placement generated approximately $27.5 million gross proceeds and included common stock and warrants, adding potential dilution. Shares outstanding increased from 27.1 million at year-end 2020 to 55.1 million at year-end 2021.
- Contingencies: The filing describes securities class and derivative actions, a contract action brought by Sabby, a potential product-marketing claim, an earn-out dispute, and an alleged patent infringement matter. A $1.3 million securities class-action settlement was agreed in principle, subject to final documents and court approval. A supplier dispute led to a $4.1 million reserve. DOE and EPA matters involving dehumidifier compliance remained unresolved or under discussion; the company said it could not estimate certain potential penalties.
Important facts for investors to verify
- Whether operating cash flow, inventory turns, and shipping and fulfillment costs improve enough to support liquidity and compliance with MidCap covenants.
- How much of reported growth is sustainable from organic operations versus acquisitions, and whether organic sales stabilize after price increases and supply disruptions.
- The impact of debt-related charges, warrants, stock compensation, and additional equity financing on cash needs and per-share dilution.
- The status and potential financial exposure of the securities and derivative litigation, supplier dispute, product compliance matters, and acquisition earn-outs.
- Whether Amazon marketplace dependence can be reduced, given its share of revenue and importance to fulfillment and receivables collection.